Trial reportPloS one2025
Could calisthenic exercises improve maximal exercise capacity, peripheral muscle strength and quality of life in dyslipidemia?
Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06008912 (Investigation of the Effect of Calisthenic Exercise Training Combined With Aerobic Exercise on Exercise Tolerance, Physical Fitness and Plasma Lipid Profile in Patients With Dyslipidemia), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Investigation of the Effect of Calisthenic Exercise Training Combined With Aerobic Exercise on Exercise Tolerance, Physical Fitness and Plasma Lipid Profile in Patients With Dyslipidemia
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRegular exercise improves cardiovascular health through regulating the plasma lipoprotein profile. But the effects of different exercise modalities on exercise capacity, muscle strength and quality-of-life in dyslipidemia is unclear.
objectivesThis study aimed to investigate the effects of calisthenic exercises on exercise capacity, muscle strength and quality-of-life in dyslipidemia.
methodsThirty-nine individuals were randomly divided into 3 groups: Aerobic + Calisthenic Exercise Group (ACG), Aerobic Exercise Group (AG) and Control Group (CG). Exercise capacity measured using cardiopulmonary exercise test, muscle strength using handheld dynamometer, quality-of-life using Short Form-36 Quality of Life Questionnaire (SF-36) at baseline and 8 weeks after.
resultsPeak oxygen uptake (VO2peak) (p < 0.001), metabolic equivalent (MET) (p < 0.001) and percentage of oxygen pulse increased significantly within ACG (p < 0.001). Peak heart rate (p = 0.006) and heart rate reserve improved significantly within AG (p = 0.004). Peak VO2 (p < 0.001), MET (p < 0.001), oxygen pulse (p = 0.006), knee extensor (p < 0.001) and handgrip strength decreased significantly within CG (p = 0.009). MET (p < 0.001) and %handgrip strength increased significantly in ACG compared to AG and CG (p = 0.021). Peak VO2 (p < 0.001), heart rate (p < 0.001), heart rate reserve (p < 0.001), and handgrip strength increased significantly in ACG compared to CG (p = 0.009). Peak heart rate (p < 0.001), heart rate reserve (p < 0.001) and shoulder abductor strength improved significantly in AG compared to CG (p = 0.019).
conclusionsAerobic exercises recommended for regulating blood biochemistry in dyslipidemia. But effects of calisthenic exercises in dyslipidemia are unclear. Our study showed that calisthenic exercises which combined with aerobic exercise training may improve cardiac and pulmonary response to exercise and handgrip strength in dyslipidemia. Additionally, aerobic exercise training may improve cardiac response to exercise in dyslipidemia. ClinicalTrials Number: NCT06008912.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.